ARCHIVES

Agency Expands Gleevec Label To Include Rare GIST Subset

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

Degarelix Approved For Advanced Prostate Cancer

January 30, 2009

Changes Put Pharma In Control Of Trials Traditionally Conducted By Academics.

March 26, 2010

Zaltrap Shows Improvement in Survival In Stage IV Metastatic Colorectal Cancer

July 29, 2011

Senate Committee Passes Bill To Speed FDA Approval Of Follow-On Biologics.

June 29, 2007

US Sues St. Luc Hospital For Grant Funds, Expenses Of Data Reanalysis, Investigation

June 9, 1995

Varmus, Branscomb Win Public Service Award From NSF; NCI Clarifies Plans For Large R01s

June 1, 2001